Helios Global
Helios Global, headquartered in Great Britain, is a leading player in the renewable energy sector, specialising in solar energy solutions and sustainable technology. Founded in 2010, the company has rapidly expanded its operations across Europe and North America, establishing a strong presence in the green energy market. With a commitment to innovation, Helios Global offers a range of unique products and services, including advanced solar panel systems and energy management solutions designed to optimise efficiency and reduce carbon footprints. The company has achieved significant milestones, such as numerous industry awards and partnerships that underscore its market position as a trusted provider of renewable energy solutions. Helios Global continues to drive the transition towards a sustainable future, making it a key contributor to the global energy landscape.
DitchCarbon Score
How does Helios Global's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Helios Global's score of 11 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Helios Global's reported carbon emissions
In 2023, Helios Global Group Limited reported total carbon emissions of approximately 7,664,800 kg CO2e, comprising about 7,664,800 kg CO2e from Scope 1 and approximately 4,620,200 kg CO2e from Scope 2 emissions. This marked a reduction from previous years, with total emissions in 2022 at about 8,516,800 kg CO2e for Scope 1 and approximately 16,692,000 kg CO2e for Scope 2. Helios Global has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2022 as the base year. This target has been validated by the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. Additionally, the company is committed to measuring and reducing its Scope 3 emissions, further enhancing its climate strategy. Overall, Helios Global's proactive approach to emissions reduction and commitment to sustainability positions it as a responsible player in the pharmaceuticals, biotechnology, and life sciences sector, headquartered in the United Kingdom.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 7,931,100 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 5,589,300 | 0,000,000 | 0,000,000 | - | - |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Helios Global is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
